Ababa, Fedelino S.
HRN: 25-74-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/02/2024
09/09/2024
IV
600
6hrs
Infected Wound
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes